Sign in

You're signed outSign in or to get full access.

Bradley Buswell

Chairman and Director at ScanTech AI Systems
Board

About Bradley Buswell

Bradley Buswell, age 61, is ScanTech AI Systems Inc.’s independent Chairman and Director (Class III), with term expiring at the 2027 annual meeting; he was appointed following the January 2025 business combination and is affirmatively determined independent under Nasdaq rules . He is a former U.S. Navy submarine officer and senior U.S. Department of Homeland Security (DHS) official, with deep security screening industry experience (Rapiscan Systems; Morpho Detection) and degrees from the U.S. Naval Academy (B.S., Systems Engineering) and George Washington University (MBA) .

Past Roles

OrganizationRoleTenureCommittees/Impact
LeidosSenior Vice President, Security Technology BusinessApr 2021–Dec 2023 Led security technology business addressing national security challenges
Rapiscan SystemsPresident, North AmericasSep 2013–Jul 2015 Launched Real Time Tomography product line; achieved U.S. government certification; secured first European airport contracts
Morpho Detection (Safran/GE Homeland Protection)President & CEOJul 2010–Jul 2013 Implemented growth-targeted strategy via internal investment and strategic acquisitions
U.S. Department of Homeland SecurityDeputy Under Secretary for Science & Technology; Acting Undersecretary (first year of Obama administration)Not disclosed Led ~1,200 staff developing technologies for TSA, CBP, USSS, FEMA; coordinated with state/local responders
General Electric Global Research CenterGovernment Relations ManagerNot disclosed Federal R&D liaison
U.S. NavySubmarine Officer20+ years Congressional Liaison for Navy R&D; Chief of Staff, Office of Naval Research

External Roles

OrganizationRoleTenureNotes
Self-employed advisorLeadership/management advisor to defense/security companiesCurrent Advises on contracting, strategic planning, execution
Other public company boardsNone disclosed

Board Governance

  • Board leadership: Independent Chairman separate from CEO; board views split roles as best practice; CEO handles strategy/operations; Chair sets agendas and presides .
  • Independence: Board determined Buswell (and McGarrity, Bottoms, Jenkins) to be independent under Nasdaq standards .
  • Class/Term: Class III; term expires at conclusion of 2027 annual meeting .
  • Risk oversight: Audit Committee oversees financial, information security/cyber/data privacy risk; Compensation oversees compensation risk; Nominating oversees independence/conflict risks; reports to full board .
  • Committee memberships (as of Oct 14, 2025):
    • Audit Committee: Co-Chair (Buswell, Jenkins co-chairs; Bottoms member) .
    • Compensation Committee: Member (Bottoms chair; Buswell and Jenkins members) .
    • Nominating & Corporate Governance Committee: Member (McGarrity chair; Buswell member) .
  • Audit Committee engagement: Signed report recommending inclusion of 2024 audited financials in Form 10-K (with Bottoms, Jenkins) .
  • Attendance: Specific board/committee attendance rates are not disclosed; committees were formed January 2025 and did not meet in 2024 .

Fixed Compensation

  • Director cash retainer, chair fees, and meeting fees: Not disclosed in the 2025 proxy; non‑employee directors (including Buswell) were appointed in January 2025 and are not included in the 2024 director compensation table .

Performance Compensation

  • Equity awards to directors: The company issued all 4,000,000 shares initially reserved under the 2025 Equity Incentive Plan during 2025 as time‑based RSUs to key employees and directors; Buswell’s beneficial ownership includes 100,000 shares issuable under RSUs within 60 days of the record date (Oct 14, 2025) .
  • Plan features impacting directors:
    • Change‑in‑control: Options become immediately exercisable; RSUs/restricted stock become fully vested; performance award conditions lapse .
    • Repricing: Underwater option repricing prohibited without stockholder approval .
    • Administration: Compensation Committee administers awards and may impose service/performance conditions .
Metric/FeatureDetail
Award typeTime‑based RSUs to directors; Buswell has 100,000 RSUs issuable within 60 days of Oct 14, 2025
Vesting scheduleSpecific director vesting dates not disclosed; RSUs counted as beneficial ownership if vest within 60 days
Change‑in‑control treatmentRSUs/restricted stock immediately vest; options immediately exercisable
Repricing policyRepricing of underwater options prohibited without stockholder approval
Performance metricsThe plan permits performance awards, but specific director performance metrics are not disclosed
2025 Plan Dilution IndicatorsAmount
Initial 2025 Plan reserve issued (time‑based RSUs)4,000,000 shares
Proposed share increase (Proposal 4)+6,800,000 shares
Total plan share limit post‑increase10,800,000 shares
Burn rate (2025, basic WACS basis)9% (not accounting for forfeitures)
Overhang (plan total vs shares outstanding)10,800,000 shares = 15.16% of 71,219,522

Other Directorships & Interlocks

CompanyRoleNotes
None disclosedNo current public company directorships or disclosed interlocks; prior employment with Rapiscan/Morpho (industry competitors) could present perceived bias but no related‑party transactions disclosed .

Expertise & Qualifications

  • Security screening industry leadership (Rapiscan/Morpho), government contracting expertise, and DHS technology oversight for TSA/CBP/USSS/FEMA; strong operational pedigree and national security coordination experience .
  • Education: U.S. Naval Academy (B.S., Systems Engineering); George Washington University (MBA) .

Equity Ownership

HolderForm of OwnershipSharesPercent of ClassNotes
Bradley BuswellRSUs issuable within 60 days of record date100,000 <1% No direct common shares disclosed; RSUs considered beneficial if vestable within 60 days
All directors & officers as a group (9)Various1,659,931 2.33% Group total disclosed
  • Hedging/pledging: Company policy prohibits hedging/monetization transactions and pledging of company securities for designated directors/officers .
  • Ownership guidelines: Not disclosed .
  • Pledged shares: None disclosed .

Governance Assessment

  • Strengths
    • Independent Chairman with deep sector and DHS leadership experience; committees balanced with independent directors; separation of Chair/CEO roles enhances oversight .
    • Audit Committee co‑chair role, with formal report recommending 2024 audited financials inclusion; clear committee charters and risk oversight allocation .
    • Anti‑hedging/pledging policy; equity plan prohibits underwater option repricing without shareholder approval .
  • Risks / Red flags
    • Nasdaq non‑compliance (bid price, market value deficiencies) with proposals for reverse splits up to an aggregate 1‑for‑250; potential for reduced liquidity and governance optics around listing maintenance .
    • Auditor resignation (UHY) citing 10‑Q filing before completion of review; company disclosed material weaknesses in ICFR in 2023–2024—heightened audit committee workload and investor confidence sensitivity .
    • Significant equity plan expansion and 10‑year evergreen proposal (+3% annually), with 2025 burn rate at 9% and total plan overhang at 15.16%—signals dilution risk and pay structure reliance on equity; board/Comp Committee must demonstrate alignment and restraint .
    • Equity line of credit (ARC Group) could result in majority ownership upon full draw (approx. 61.93% of outstanding), creating potential change‑of‑control dynamics—board should ensure robust minority protections and disclosures .

Overall, Buswell’s independence, sector expertise, and audit leadership are positives for board effectiveness. The contemporaneous audit/internal control issues, listing compliance challenges, and aggressive equity plan design elevate governance and dilution risk; sustained audit remediation, transparent director pay disclosure, and prudent use of equity financing are critical to investor confidence .